Issue 13, 2020

The synthesis and characterization of 3D mesoporous CeO2 hollow spheres as a modifier for the simultaneous determination of amlodipine, hydrochlorothiazide and valsartan

Abstract

Herein, mesoporous CeO2 hollow spheres (M-CeO2-HSs) with a three-dimensional configuration were synthesized via a facile strategy. The morphology and structure of the three-dimensional M-CeO2-HSs were characterized via XRD, SEM, and EDX. In order to demonstrate their practical application, the as-prepared M-CeO2-HSs were applied as a modifier, which exhibited high catalytic activity for the simultaneous detection of amlodipine (AML), hydrochlorothiazide (HCTZ) and valsartan (VAL). Furthermore, a modified electrode was fabricated and investigated via electrochemical impedance spectroscopy (EIS). An unmodified GCE and the M-CeO2-HS-modified glassy carbon electrode (M-CeO2-HS/GCE) were utilized to assess their electrochemical behaviors towards AML, HCTZ and VAL. It was observed that the electrochemical responses of M-CeO2-HS/GCE towards these analytes were remarkably enhanced. M-CeO2-HS/GCE exhibited satisfactory responses for AML, HCTZ and VAL with detection limits of 7.9 nmol L−1, 3.8 nmol L−1 and 5.4 nmol L−1 (S/N = 5), respectively. The diffusion coefficient (D) and heterogeneous rate constant (kh) were detected for the oxidation of AML, HCTZ and VAL on the surface of the modified electrode. In addition, the analytical application of M-CeO2-HS/GCE was investigated, which demonstrated acceptable results for the simultaneous detection of AML, HCTZ and VAL in real specimens.

Graphical abstract: The synthesis and characterization of 3D mesoporous CeO2 hollow spheres as a modifier for the simultaneous determination of amlodipine, hydrochlorothiazide and valsartan

Article information

Article type
Paper
Submitted
04 Jan 2020
Accepted
29 Feb 2020
First published
06 Mar 2020

Anal. Methods, 2020,12, 1767-1778

The synthesis and characterization of 3D mesoporous CeO2 hollow spheres as a modifier for the simultaneous determination of amlodipine, hydrochlorothiazide and valsartan

N. Farvardin, S. Jahani, M. Kazemipour and M. M. Foroughi, Anal. Methods, 2020, 12, 1767 DOI: 10.1039/D0AY00022A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements